CHARLOTTE, N.C., Oct. 13, 2017 -- Coca-Cola Bottling Co. Consolidated (NASDAQ:COKE) announced that the Board of Directors has declared a dividend for the fourth quarter of 2017 of $.25 per share on shares of the Company's Common Stock and Class B Common Stock payable on November 10, 2017 to shareholders of record as of the close of business on October 27, 2017.
About Coca-Cola Bottling Co. Consolidated
Coke Consolidated is the largest independent Coca-Cola bottler in the United States. Our Purpose is to honor God, serve others, pursue excellence and grow profitably. For 115 years, we have been deeply committed to the consumers, customers and communities we serve and passionate about the broad portfolio of beverages and services we offer. We make, sell and distribute beverages of The Coca-Cola Company and other partner companies in more than 300 brands and flavors across 15 states to over 66 million consumers.
Headquartered in Charlotte, N.C., Coke Consolidated is traded on the NASDAQ under the symbol COKE. More information about the company is available at www.cokeconsolidated.com. Follow Coke Consolidated on Facebook, Twitter, Instagram and LinkedIn.
–Enjoy Coca-Cola–
Media Contact:
Kimberly Kuo
Senior Vice President, Public Affairs, Communications and Communities
704-557-4584
Investor Contact:
Clifford M. Deal, III
Senior Vice President and Chief Financial Officer
704-557-4633


Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 



